Regulatory Strategy Consulting Services
Accelerate your path to approval with QNova LifeSciences.
We guide biotech, pharmaceutical, and medical device companies through complex regulatory pathways worldwide — from discovery through commercialization. By combining scientific expertise with regulatory insight, we reduce risk, shorten timelines, and increase the probability of approval success.
- 30+ FDA Special Designations secured
- 250+ successful FDA medical device submissions (Class I & II)
- 65+ NDA, BLA, 505(b)(1), and 505(b)(2) approvals
- 500+ therapeutic projects supported across drugs, biologics, and devices
With QNova, you gain a strategic regulatory partner that reduces risk, shortens timelines, and increases the probability of regulatory success.
Introduction (Strategic Guidance for Regulatory Success)
The regulatory environment is constantly evolving, with global authorities introducing new guidelines and expectations that can delay or derail approvals. For emerging biotech and medtech companies, navigating this landscape without expert guidance can waste valuable time and resources.
QNova LifeSciences offers regulatory strategy consulting that integrates scientific expertise, regulatory intelligence, and global market insight. Our approach aligns nonclinical, CMC, and clinical strategies into a cohesive development plan that satisfies regulators and accelerates your path to patients.
We bring:
- Integrated lifecycle expertise (CMC, nonclinical, clinical, and commercial)
- Global regulatory insight (FDA, EMA, MHRA, PMDA, Health Canada, NMPA, and beyond)
- Proven success rates across both drugs and medical devices
- Flexible, on-demand teams for emerging and growth-stage companies
Core Regulatory Strategy Services
Effective regulatory planning requires both vision and detail. We deliver a suite of services that cover the full regulatory lifecycle, from planning to submissions and beyond.
Our approach ensures your product is supported by a strategy that is compliant, commercially sound, and tailored to your development stage.
End-to-End Regulatory Lifecycle Support
Your product’s success depends on a roadmap that anticipates risks and prepares for milestones. We design strategies that anticipate challenges, resolve gaps, and set clear milestones for success. From initial planning to post-market obligations, we ensure every stage of your program is aligned with agency expectations.
We provide regulatory support from early planning through post-approval:
- Development of regulatory roadmaps tailored to your product
- Gap assessments to identify deficiencies in CMC, nonclinical, or clinical packages
- Regulatory milestone planning (Pre-IND, IND, NDA/BLA, ANDA, MAA)
- Post-marketing compliance including surveillance and label maintenance
- Cross-functional coordination with clinical ops, CMC, commercial, and medical affairs teams
Global Regulatory Strategy & Submissions
Global development requires foresight and precision. We help companies navigate submissions in multiple jurisdictions, building strategies that maximize efficiency and reduce risk of regulatory setbacks.
QNova supports worldwide regulatory engagement, submissions, and approvals:
- IND, CTA, NDA, BLA, ANDA, MAA submissions
- Device submissions: 510(k), De Novo, PMA, CE Marking
- Regulatory due diligence and landscape assessments
- Representation before FDA, EMA, MHRA, PMDA, Health Canada, NMPA, and other agencies
- FDA Meetings (Pre-IND, EOP1/EOP2, Pre-NDA/BLA, Pre-Sub, Q-Sub)
- Special designations: Orphan, Fast Track, Breakthrough Therapy, RMAT
- U.S. FDA Agent representation for non-U.S. companies
CMC and Nonclinical Regulatory Support
Strong Chemistry, Manufacturing, and Controls (CMC) and nonclinical strategies form the foundation of a successful submission. We help ensure your data packages are comprehensive, compliant, and scientifically sound.
- CMC development planning and document preparation
- API and formulation development, stability testing, GMP compliance
- IND-enabling toxicology and GLP safety studies
- Dose formulation, PK/PD studies, and immunogenicity assessments
- Preclinical protocol design and regulatory alignment
- Vendor audits and quality oversight
Clinical Development Regulatory Strategy
Clinical trial design and execution must align with agency expectations to avoid costly holds or rework. We partner with clinical teams to build programs that are efficient, ethical, and approval-ready. We help ensure your clinical development programs are aligned with regulatory expectations:
- Clinical protocol design and endpoint selection
- FDA/EMA scientific advice and feedback integration
- Support for adaptive trial designs and expedited programs
- Pediatric Investigational Plans (PIPs) and Pediatric Study Plans (PSPs)
- Expanded access and compassionate use programs
Specialized Expertise and Consulting Services
Beyond core regulatory strategy, we offer specialized consulting for high-stakes situations — from advisory committee hearings to product claims substantiation. Our team ensures you are prepared to defend your science, strategy, and compliance.
FDA Advisory Committee & EMA Oral Explanation Preparation
We help you prepare for critical regulatory meetings that influence approvals and market access.
- Briefing document preparation and scientific data review
- Core presentations, backup slides, and briefing books
- Mock panel rehearsals and message testing
- Regulatory coaching for sponsor teams
Scientific and Marketing Claims Substantiation
Product messaging must align with both science and regulation. Our team validates your claims to ensure compliance and credibility.
- Review and validation of promotional claims
- Scientific substantiation strategies for FDA compliance
- Ingredient safety assessments and labeling reviews
Expert Witness and Regulatory Testimony
In high-stakes disputes, regulatory expertise can make the difference. We provide support in litigation, compliance challenges, and IP disputes.
We offer:
- Support in high-stakes disputes involving FDA-regulated products
- Testimony on regulatory compliance, product safety, and labeling issues
- Litigation support for IP challenges, product claims, and regulatory actions
Quality, Compliance & Audit Readiness
Quality and compliance are critical not only for approvals but also for long-term market success. We design quality systems and audit-readiness programs that keep your organization inspection-ready.
Quality Management System Development
Quality systems form the backbone of compliance. Our team builds and implements QMS structures that meet international standards and withstand regulatory audits.
Key components:
- ISO 13485 and 21 CFR Part 820-compliant QMS
- SOP development and document control
- CAPA management and deviation tracking
- Training and audit preparedness
- Supplier and contract manufacturer qualification
Due Diligence and Gap Assessments
For investors, acquirers, and licensing partners, regulatory risk is business risk. Our assessments provide the clarity needed for confident decisions.
Services include:
- M&A and licensing regulatory due diligence
- Evaluation of regulatory and reimbursement landscapes
- Assessment of eligibility for FDA/EMA Special Designations
- Risk mitigation planning and investor readiness reports
Cross-Functional & Technology-Enabled Solutions
Today’s regulatory environment demands cross-functional alignment and digital tools that streamline processes. Clients benefit from integrated teams and technology platforms that keep development moving efficiently.
Integrated Global Teams
Collaboration across functions ensures regulatory success. By uniting experts in regulatory, clinical, and commercialization, development strategies remain cohesive and milestone-driven.
- Collaboration across CMC, clinical ops, biostatistics, HEOR, medical writing, and commercialization
- Localized expertise with global regulatory reach
- Seamless communication and milestone alignment
Regulatory Technology Tools
Technology reduces complexity and improves oversight in regulatory programs. Clients gain visibility, control, and efficiency through our digital tools.
- eCTD publishing and submission tracking systems
- Document control and version management
Agency Engagement & Meeting Support
Authority meetings shape the trajectory of approvals. By anticipating questions and coaching teams, we help clients approach FDA, EMA, and other regulators with confidence.
Health Authority Meeting Preparation
Successful meetings depend on preparation and clarity. Our team develops the materials and strategies needed to engage regulators productively.
Support includes:
- Pre-IND, End of Phase I/II, and Pre-NDA/BLA packages
- Scientific advice meeting preparation (FDA, EMA, MHRA, PMDA)
- Mock Q&A sessions and rehearsal meetings
- Post-meeting strategy development and follow-up plans
Therapeutic and Product Type Coverage
Our consultants support diverse pipelines across therapeutic areas and product classes. This breadth ensures tailored strategies for each product’s unique challenges.
Product Classes
- Biologics, biosimilars, and gene therapies
- Small molecules and NCEs
- Drug-device combination products
- Medical devices, diagnostics, and digital health products
- Nutritional supplements, OTC, medical foods
Therapeutic Areas
- Oncology, CNS, rare diseases, immunology
- Infectious disease, cardiovascular, dermatology
- Pulmonary, gastroenterology, endocrinology
- Veterinary medicine and emerging therapeutic areas
Why Choose QNova LifeSciences
Choosing a regulatory partner is about trust, experience, and results. Clients value our proven track record, integrated approach, and global perspective.
- Proven Record of Success: 30+ FDA Special Designations, 500+ therapeutic projects supported
- Integrated Global Expertise: Regulatory, scientific, and commercialization under one roof
- Flexible Engagement Models: On-demand, scalable teams for early- and late-stage companies
- Global Reach: FDA, EMA, MHRA, PMDA, Health Canada, and beyond
- Patient-Centered Focus: Every strategy is built to accelerate access to innovative therapies
Frequently Asked Questions
What is regulatory strategy consulting?
It is expert guidance that integrates scientific, regulatory, and business insights to help companies navigate complex health authority requirements and secure product approvals efficiently.
Which regulatory agencies does QNova work with?
We regularly support interactions with FDA, EMA, MHRA, PMDA, Health Canada, NMPA, and other agencies worldwide.
Can QNova support medical device regulatory consulting?
Yes — we provide De Novo, 510(k), and PMA submissions, CE Marking, QMS development, and global expansion filing support.
Do you offer due diligence services for investors and M&A?
Yes — we provide regulatory due diligence and risk-based assessments for product licensing, acquisitions, and investor readiness.
Does QNova offer FDA representation for non-U.S. companies?
Yes — we act as U.S. FDA Agent for international biotech and medtech companies.
Explore Related Services
Partner with QNova LifeSciences
Partner with QNova LifeSciences to accelerate your product’s regulatory journey.
Our team provides the experience, strategy, and global insight needed to de-risk development and achieve approvals faster.